Article, Clinical Trials, Epilepsy and Seminar

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Article

Clinical Trials

Epilepsy

Seminar

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Refractory paediatric epilepsy. Conclusions.

Research and Development

Research and Development Medicine Access Media

A Hidden Origin Story of the CBD Craze

SMPL

MAY 26, 2020

fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. In 2020, CBD is available three ways: over the counter; at state-licensed marijuana dispensaries; or if you have certain forms of epilepsy, from GW Pharmaceuticals. Read the full article here. And because of public demand, the F.D.A.

CBD

CBD Research and Development Pharmaceutical Seed-To-Sale

Medical Cannabis Brief

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

A Hidden Origin Story of the CBD Craze

Stay Connected